Does improvement of cognitive functioning by cognitive remediation therapy effect work outcomes in severe mental illness? A secondary analysis of a randomized controlled trial

被引:19
|
作者
Ikebuchi, Emi [1 ]
Sato, Sayaka [2 ]
Yamaguchi, Sosei [2 ]
Shimodaira, Michiyo [3 ]
Taneda, Ayano [2 ]
Hatsuse, Norifumi [1 ]
Watanabe, Yukako [1 ]
Sakata, Masuhiro [4 ]
Satake, Naoko [4 ]
Nishio, Masaaki [5 ]
Ito, Jun-ichiro [6 ]
机构
[1] Teikyo Univ, Sch Med, Dept Psychiat, Tokyo, Japan
[2] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Psychiat Rehabil, Tokyo, Japan
[3] Univ Tokyo, Grad Sch Med, Dept Mental Health Psychiat Nursing, Tokyo, Japan
[4] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Tokyo, Japan
[5] Tohoku Fukushi Univ, Sch Welf, Sendai, Miyagi, Japan
[6] ACT J Team, Sendai, Miyagi, Japan
关键词
cognitive functioning; cognitive remediation; schizophrenia; supported employment; working life; SUPPORTED EMPLOYMENT; SCHIZOPHRENIA; METAANALYSIS; REHABILITATION; PEOPLE; HEALTH; SCALE;
D O I
10.1111/pcn.12486
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aim: The aim of this study was to clarify whether improvement of cognitive functioning by cognitive remediation therapy can improve work outcome in schizophrenia and other severe mental illnesses when combined with supported employment. Methods: The subjects of this study were persons with severe mental illness diagnosed with schizophrenia, major depression, or bipolar disorder (ICD-10) and cognitive dysfunction who participated in both cognitive remediation using the Thinking Skills for Work program and a supported employment program in a multisite, randomized controlled study. Logistic and multiple linear regression analyses were performed to clarify the influence of cognitive functioning on vocational outcomes, adjusting for demographic and clinical variables. Results: Improvement of cognitive functioning with cognitive remediation significantly contributed to the total days employed and total earnings of competitive employment in supported employment service during the study period. Any baseline demographic and clinical variables did not significantly contribute to the work-related outcomes. Conclusion: A cognitive remediation program transferring learning skills into the real world is useful to increase the quality of working life in supported employment services for persons with severe mental illness and cognitive dysfunction who want to work competitively.
引用
收藏
页码:301 / 308
页数:8
相关论文
共 50 条
  • [41] Cognitive training and supported employment for persons with severe mental illness: One-year results from a randomized controlled trial
    McGurk, SR
    Mueser, KT
    Pascaris, A
    SCHIZOPHRENIA BULLETIN, 2005, 31 (04) : 898 - 909
  • [42] Evaluation of an Adaptive Implementation Program for Cognitive Adaptation Training for People With Severe Mental Illness: a cluster-randomized controlled trial
    Van Der Meer, L.
    Van Dam, M.
    Van Weeghel, J.
    Castelein, S.
    Pijnenborg, G.
    EUROPEAN PSYCHIATRY, 2022, 65 : S754 - S754
  • [43] Can computer-assisted cognitive remediation improve employment and productivity outcomes of patients with severe mental illness? A meta-analysis of prospective controlled trials
    Chan, Joyce Y. C.
    Hirai, Hoyee W.
    Tsoi, Kelvin K. F.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2015, 68 : 293 - 300
  • [44] Randomized controlled trial of cognitive behavioral therapy for perinatal insomnia: postpartum outcomes
    Manber, Rachel
    Bei, Bei
    Suh, Sooyeon
    Simpson, Norah
    Rangel, Elizabeth
    Sit, Anita
    Lyell, Deirdre J.
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2023, 19 (08): : 1411 - 1419
  • [45] Changes in BDNF methylation patterns after cognitive remediation therapy in schizophrenia: A randomized and controlled trial
    Penades, Rafael
    Almodovar-Paya, Carmen
    Garcia-Rizo, Clemente
    Ruiz, Victoria
    Catalan, Rosa
    Valero, Sergi
    Wykes, Til
    Fatjo-Vilas, Mar
    Arias, Barbara
    JOURNAL OF PSYCHIATRIC RESEARCH, 2024, 173 : 166 - 174
  • [46] Efficacy and Feasibility of Remote Cognitive Remediation Therapy in Parkinson's Disease: A Randomized Controlled Trial
    Hoffman, Lisa
    Burt, Nicholas D. D.
    Piniella, Nicholas R. R.
    Baker, Madison
    Volino, Nicole
    Yasin, Saeed
    Jung, Min-Kyung
    Leder, Adena
    Sousa, Amber
    PARKINSONS DISEASE, 2023, 2023
  • [47] Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1 - A randomized controlled trial
    Krab, Lianne C.
    de Goede-Bolder, Arja
    Aarsen, Femke K.
    Pluijm, Saskia M. F.
    Bouman, Marlies J.
    van der Geest, Jos N.
    Lequin, Maarten
    Catsman, Coriene E.
    Arts, Willem Frans M.
    Kushner, Steven A.
    Silva, Alcino J.
    de Zeeuw, Chris I.
    Moll, Henriette A.
    Elgersma, Ype
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (03): : 287 - 294
  • [48] Effect of Action-Based Cognitive Remediation on cognitive impairment in patients with remitted bipolar disorder: A randomized controlled trial
    Ott, Caroline, V
    Vinberg, Maj
    Kessing, Lars, V
    Bowie, Christopher R.
    Forman, Julie L.
    Miskowiak, Kamilla W.
    BIPOLAR DISORDERS, 2021, 23 (05) : 487 - 499
  • [49] Effect of Computer-Assisted Cognitive Remediation Therapy on Cognition among Patients with Schizophrenia: A Pilot Randomized Controlled Trial
    Yamanushi, Ayumi
    Shimada, Takeshi
    Koizumi, Ami
    Kobayashi, Masayoshi
    BIOMEDICINES, 2024, 12 (07)
  • [50] Narrative enhancement and cognitive therapy (NECT) to improve social functioning in people with serious mental illness: study protocol for a stepped-wedge cluster randomized controlled trial
    Dubreucq, J.
    Faraldo, M.
    Abbes, M.
    Ycart, B.
    Richard-Lepouriel, H.
    Favre, S.
    Jermann, F.
    Attal, J.
    Bakri, M.
    Cohen, T.
    Cervello, C.
    Chereau, I
    Cognard, C.
    De Clercq, M.
    Douasbin, A.
    Giordana, J. Y.
    Giraud-Baro, E.
    Guillard-Bouhet, N.
    Legros-Lafarge, E.
    Polosan, M.
    Pouchon, A.
    Rolland, M.
    Rainteau, N.
    Roussel, C.
    Wangermez, C.
    Yanos, P. T.
    Lysaker, P. H.
    Franck, N.
    TRIALS, 2021, 22 (01)